Clinical Research Focus. 49th Edition Clinical Research Focus featuring topical articles of interest to the clinical trial community. Explore the news of February 2026. Read more
After JPM 2026: Where Healthcare Strategy Is Actually Heading By Vlad Bogin, MD, FACP CEO, Cromos Pharma The J.P. Morgan Healthcare Conference has always been a defining moment for the healthcare industry, not because of a single announcement, but because of the collective direction that emerges once the week is over. JPM 2026 followed that pattern, but with a noticeable shift in tone. This Read more
Clinical trial trends 2026
Clinical Research in 2026: What Changed — and Why It Matters  Key Takeaways   Clinical research is becoming more selective, not slower.  Capital, regulation, and policy volatility are forcing sharper prioritization and earlier decisions.  Execution quality now carries financial consequences.  Late-stage trials leave little room for operational error, weak endpoints, or slow enrollment.  Risk is moving upstream.  AI, alternative preclinical models, and modular global development are shifting decision-making earlier.  Read more
Neurology CRO: Key Challenges in CNS Clinical Trials Neurology clinical trials present distinct challenges for drug developers, from patient recruitment and retention to endpoint variability, placebo response, and long study durations. These factors can complicate trial execution and make reliable assessment of treatment effects particularly difficult. For sponsors developing therapies for Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, epilepsy, and other neurological conditions, selecting Read more

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us